Blog

Florian Lordick: Niche2 data presented by Myriam Chalabi

Photo of Florian Lordick and Myriam Chalabi

Sep 21, 2024, 13:13

Florian Lordick: Niche2 data presented by Myriam Chalabi

Florian Lordick, Professor of Medicine at University of Leipzig and Director of the Comprehensive Cancer Center Central Germany, shared a post on LinkedIn:

”ESMO24 exciting colorectal proffered paper session Niche2 data presented by Myriam Chalabi.

Unpredented 100% DFS with neoadjuvant Nivolumab-Ipilimumab for locally advanced colon cancer. Prediction of pCR still difficult. ctDNA may help.”

Florian Lordick

Source: Florian Lordick/LinkedIn

cancer Colon cancer Comprehensive Cancer Center Central Germany ESMO24 Florian Lordick ipilimumab Myriam Chalabi nivolumab OncoDaily Oncology University of Leipzig

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage